Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-02-01 @ 6:13 PM
Study NCT ID:
NCT00968760
Status:
COMPLETED
Last Update Posted:
2023-12-19
First Post:
2009-08-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | CD19+ lymphoid malignancies | View |
| None | non-Hodgkin's Lymphoma | View |
| None | NHL | View |
| None | small lymphocytic lymphoma | View |
| None | SLL | View |
| None | follicular lymphoma | View |
| None | mantle cell lymphoma | View |
| None | gene cell transfer | View |
| None | CD19-specific T cells | View |
| None | Stem Cell Transplant | View |
| None | T Cell Infusion | View |
| None | Chemotherapy | View |
| None | Leukapheresis | View |
| None | BCNU | View |
| None | carmustine | View |
| None | Cytarabine | View |
| None | Etoposide | View |
| None | Interleukin-2 | View |
| None | Proleukin | View |
| None | Melphalan | View |
| None | Rituximab | View |
| None | T cell therapy | View |